Portfolio Management · INTERMEDIATE

Robust Multi-Factor Committee

Full universe -> filter -> parallel fetch -> macro/news/quant -> fusion -> ranking -> constraints -> final decision pipeline.

Simulated return

-0.77%

from $100,000 · since 25 Aug 2026

Last run 5 Oct 2026

Portfolio value

$99,235

Cash

$26,284

Decisions

Max drawdown

-2.73%

Current holdings

XOMExxon Mobil Corporation

$7,771

7.8% of portfolio

Oil price support, capital discipline, and dividends/buybacks support energy value tilt.

CVXChevron Corporation

$7,631

7.7% of portfolio

Oil price support, capital discipline, and dividends/buybacks support energy value tilt.

NVDANVIDIA Corporation

$7,566

7.6% of portfolio

AI Capex and cloud demand drive semiconductor growth; tech momentum tilt.

MSFTMicrosoft Corporation

$7,491

7.5% of portfolio

AI-related capital expenditure and cloud demand support growth; quality tech tilt.

KOThe Coca-Cola Company

$7,396

7.5% of portfolio

Defensive quality with positive 200-day trend; traditional quality name.

DHRDanaher Corporation

$7,256

7.3% of portfolio

Recovery in bioprocessing/diagnostics and healthcare policy updates support growth.

UNHUnitedHealth Group Incorporated

$7,207

7.3% of portfolio

Healthcare policy updates and product/pipeline news support recovery.

JNJJohnson & Johnson

$7,059

7.1% of portfolio

Healthcare policy updates and product/pipeline news support quality tilt.

JPMJPMorgan Chase & Co.

$6,993

7.0% of portfolio

Rate trajectory, net interest income, and buybacks support financials value and momentum.

VZVerizon Communications Inc.

$6,581

6.6% of portfolio

Wireless pricing, subscriber trends, and dividend support defensive communication exposure.

Decision log

Every trade this strategy placed, with the reasoning recorded at the moment of the decision.

SELLJNJ0.597 @ 271.22 USD$162
Memo offers no new evidence or recommendation; per the memo, no state-changing action is executed. HOLD explicitly retains the existing JNJ position at its current 7.5% target.
27 Sept 2026
BUYUNH0.648 @ 376.59 USD$244
Memo offers no new evidence or recommendation; per the memo, no state-changing action is executed. HOLD explicitly retains the existing UNH position at its current 7.5% target.
27 Sept 2026
BUYJPM0.699 @ 343.06 USD$240
Memo offers no new evidence or recommendation; per the memo, no state-changing action is executed. HOLD explicitly retains the existing JPM position at its current 7.5% target.
27 Sept 2026
BUYVZ9.09 @ 47.08 USD$428
Memo offers no new evidence or recommendation; per the memo, no state-changing action is executed. HOLD explicitly retains the existing VZ position at its current 7.5% target.
27 Sept 2026
SELLNVDA0.903 @ 225.07 USD$203
Memo offers no new evidence or recommendation; per the memo, no state-changing action is executed. HOLD explicitly retains the existing NVDA position at its current 7.5% target.
27 Sept 2026
SELLDHR1.71 @ 224.65 USD$384
Memo offers no new evidence or recommendation; per the memo, no state-changing action is executed. HOLD explicitly retains the existing DHR position at its current 7.5% target.
27 Sept 2026
SELLMSFT0.25 @ 516.17 USD$129
Memo offers no new evidence or recommendation; per the memo, no state-changing action is executed. HOLD explicitly retains the existing MSFT position at its current 7.5% target.
27 Sept 2026
BUYXOM46.855 @ 160.07 USD$7,500
Strong momentum: +6.4% vs 50d, +11.5% vs 200d; energy up sharply; capital discipline and dividends.
31 Aug 2026
BUYKO84.062 @ 89.22 USD$7,500
Positive momentum: +4.6% vs 50d, +14.2% vs 200d; consumer staples quality/defensive exposure.
31 Aug 2026
BUYDHR34.959 @ 214.535 USD$7,500
Positive momentum: +7.9% vs 50d, +5.8% vs 200d; beta 0.80 provides low-vol tilt; healthcare/life sciences exposure.
31 Aug 2026
BUYJNJ28.137 @ 266.55 USD$7,500
Positive momentum: +3.3% vs 50d, +14.0% vs 200d; traditional healthcare quality/value name.
31 Aug 2026
BUYJPM21.074 @ 355.885 USD$7,500
Positive momentum: +2.7% vs 50d, +12.4% vs 200d; beta 0.98 adds low-vol tilt; financials value/quality exposure.
31 Aug 2026
BUYUNH19.187 @ 390.9 USD$7,500
Above 200-day (+11.8%) but below 50-day (-5.2%); included with lower tactical weight justification despite short-term pullback.
31 Aug 2026
BUYVZ149.566 @ 50.145 USD$7,500
Positive momentum: +8.9% vs 50d, +10.1% vs 200d; communication services dividend payer.
31 Aug 2026
BUYNVDA34.091 @ 220 USD$7,500
Positive momentum: +5.5% vs 50d, +12.3% vs 200d; AI semiconductor leader.
31 Aug 2026
BUYMSFT14.721 @ 509.47 USD$7,500
Strong momentum: +18.3% vs 50d, +18.2% vs 200d; tech quality leader with AI/cloud exposure.
31 Aug 2026
BUYCVX36.374 @ 206.19 USD$7,500
Strong momentum: +10.0% vs 50d, +14.7% vs 200d; energy up sharply; capital discipline and dividends.
31 Aug 2026

Read the full analysis behind each trade

A free account unlocks the complete reasoning for every decision above, the data the AI pulled to reach it, and the ability to run this strategy against your own portfolio.

Create a free account

No card required.

Simulated portfolios. Each strategy runs on a hypothetical $100,000 account with no real money at risk, and results do not include the slippage, fees, or fill constraints of live trading. Past and simulated performance does not indicate future results. Nothing here is investment advice.